Browsing "Comunicações em Eventos - LIM/24" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 537 to 556 of 577 < previous   next >
Issue DateTitleAuthor(s)
2018Tackling mammary tumors by disrupting cancer stem cells via modulation of developmental signaling pathways.RANGEL, Maria Cristina; RAAFAT, Ahmed; CASTRO, Nadia P.; KLAUZINSKA, Malgorzata; KOSAKOWSKA-CHOLODY, Teresa; BEHBOD, Fariba; LOCKETT, Stephen; CALLAHAN, Robert; CHAMMAS, Roger; SALOMON, David
2014Targeting HSP90 in breast cancer: Enchant-1 (NCT01677455) phase 2 proof of concept study of ganetespib in first-line treatment of women with metastatic breast cancerCAMERON, David A.; SPECTOR, Neil; CORTES, Javier; MANO, Max S.; CANON, Jean-Luc Re; HICKISH, Tamas; VANDAT, Linda T.; KIM, Sung-Bae; GOMEZ, Henry Leonidas; EL-HARIRY, Iman, et al
2022Targeting PIP4K2 Lipid Kinases through Thz-P1-2 Reveals Vulnerabilities Related to Mitochondrial Homeostasis and Autophagy in Acute LeukemiaLIMA, Keli; PEREIRA-MARTINS, Diego A.; MIRANDA, Livia Bassani Lins de; COELHO-SILVA, Juan L.; LEANDRO, Giovana da Silva; WEINHAUSER, Isabel; CAVAGLIERI, Rita de Cassia; SILVA, Wellington F.; LEAL, Aline Medeiros; LANGE, Ana Paula Alencar de Lima, et al
2017(TC)-T-99M-MIBI SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY-COMPUTED TOMOGRAPHY (SPECT-CT) TO DETECT TUMOR PROGRESSION IN GLIOBLASTOMAS (GB)VICTOR, Carolina; LOPEZ, Rossana; NUNES, Rafael; MARTA, Gustavo; PICARELLI, Helder; BUCHPIGUEL, Carlos Alberto; FEHER, Olavo
2013THE AGE-SPECIFIC DISTRIBUTION OF GENITAL HUMAN PAPILLOMAVIRUS (HPV) INFECTION AND HERPES SIMPLEX VIRUS-2 (HSV-2) ANTIBODIES AMONG MEN WITH GENDER-FIXED AND GENDER-FLUID SEXUAL BEHAVIOUR: THE HIM STUDYNYITRAY, A. G.; ROSS, M. W.; WILKERSON, M.; VILLA, L. L.; ABRAHAMSEN, M.; PAPENFUSS, M.; LAZCANO-PONCE, E.; GIULIANO, A. R.
2014The consistency of effect of ziv-aflibercept (Z) in the bevacizumab (B) pre-treated subgroup of patients (pts) in the velour trial stratified by first-line progression >= 9 months (mos) versus < 9 mos.HOFF, Paulo Marcelo; HAZEL, Guy Van; CUNNINGHAM, David; ARNOLD, Dirk; SCHMOLL, Hans; TIJE, Albert J. Ten; NAOSHY, Sarah; JOULAIN, Florence; MCKENDRICK, Joseph; VISHWANATH, Raghu L., et al
2014The effect of chemotherapy delivered until progression versus complete stop on the overall survival of patients with metastatic colorectal cancer: A meta-analysis of randomized trials.PEREIRA, Allan Andresson Lima; REGO, Juliana Florinda De Mendonga; HOFF, Paulo Marcelo; SASSE, Andre Deeke; RIECHELMANN, Rachel Pimenta
2018The effects of saliva exosome-like extracellular vesicles from locally advanced OSCC patients on OSCC cell linesBISPO, Karina A.; GARCIA, Fabyane O. T.; CARVALHO, Tarcia A. C. B.; MAK, Milena P.; CASTRO JR., Gilberto de; PASINI, Fatima S.
2013The ENCHANT-1 trial (NCT01677455): An open label multicenter phase 2 proof of concept study evaluating first line ganetespib monotherapy in women with metastatic HER2 positive or triple negative obreast cancer (TNBC)AWADA, A.; SPECTOR, N.; EL-HARIRY, I.; RODRIGUEZ, A. A.; ERBAN, J. K.; CORTES, J.; GOMEZ, H.; KONG, A.; HICKISH, T.; FEIN, L., et al
2012THE ENCHANTTM TRIAL: AN OPEN LABEL MULTICENTER PHASE 2 WINDOW OF OPPORTUNITY STUDY EVALUATING GANETESPIB (STA-9090) MONOTHERAPY IN WOMEN WITH PREVIOUSLY UNTREATED METASTATIC HER2 POSITIVE OR TRIPLE NEGATIVE BREAST CANCER (TNBC)CAMERON, D.; MANO, M. S.; VUKOVIC, V.; TEOFILOVICI, F.; BRADLEY, R.; AWADA, A.
2015The impact of the time to start radiotherapy (TRT) on overall survival in newly diagnosed glioblastoma.SANTOS, Vanessa Montes; MESQUITA, Marcella Coelho; ESTEVEZ-DIZ, Maria Del Pilar; MARTA, Gustavo N.; FEHER, Olavo
2015THE PARACONSISTENT METHOD AS AN AID TO TAKING DECISIONS IN HEALTHCAMPOLINA, A. G.; COSTA, A.; V, R. Lopez
2014The precursor miR-138/2, but not miR-138/1, targets p53 mRNA and contributes to the acquisition of melanoma metastatic phenotype: Are the miRNAs precursors important to direct mature miRNA to mRNA targetsCRUZ, Adriana Taveira Da; HUNGER, Aline; PARE, Genevieve; LAI, Dulcie; MELO, Fabiana Henriques Machado; STRAUSS, Bryan Eric; TRON, Victor; JASIULIONIS, Miriam Galvonas
2012THE QUALITY OF SAMPLE SIZE CALCULATION (SSC) REPORTING IN CANCER CLINICAL TRIALSBARIANI, G. M.; FERRARI, A. C. R. C.; HOFF, P. M.; ARAI, R.; PRECIVALE, M.; RIECHELMANN, R. P.
2015The role of LHRH agonists in ovarian function preservation in premenopausal women undergoing chemotherapy for early stage breast cancer: A systematic review and meta-analysisMUNHOZ, Rodrigo Ramella; PEREIRA, Allan Andresson Lima; SASSE, Andre Deeke; HOFF, Paulo Marcelo; TRAINA, Tiffany A.; HUDIS, Clifford A.; MARQUES, Ricardo Jose
2020Time to central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with cobimetinib (C) plus vemurafenib (V) in the phase Ill IMspire150 study.ASCIERTO, Paolo Antonio; ROBERT, Caroline; LEWIS, Karl D.; MUNHOZ, Rodrigo; LISZKAY, Gabriella; MERINO, Luis de la Cruz; OLAH, Judit; QUEIROLO, Paola; MACKIEWICZ, Jacek; LI, Haocheng, et al
2015TISSUE EXPRESSION OF SUPEROXIDE DISMUTASE-2 AS A MARKER OF INTRAEPITELIAL NEOPLASIA AND INVASIVE CERVICAL CARCINOMARABELO-SANTOS, S. H.; VILLA, L. L.; TERMINI, L.; LONGATTO, A.; ANDREOLI, M. A.; ANGELO-ANDRADE, L. A. L.; DERCHAIN, S.; ZEFERINO, L. Carlos
2016Tolerability of modified gemcitabine/docetaxel (split-dose) in patients with advanced soft tissue sarcomasAZEVEDO, R. G. M. V. D.; FRAILE, N.; SAADI NETO, E.; LOPEZ, R. V. M.; TOLOI, D.; HOFF, P. M.; FEHER, O.; CAMARGO, V. P. D.; MUNHOZ, R.
2015Transcriptome analysis of MCF7 breast cancer cells with different expression profile of PAR-4 (prostate apoptosis response-4) in the presence and absence of docetaxelGARCIA, Simone A. de Bessa; PAVANELLI, Ana C.; MELO, Natalia C.; NAGAI, Maria A.
2018Transcriptome and proteome analyses of MCF7 cells with different expression profile of SPARC (secreted protein acidic in rich in cysteine) in the presence and absence of docetaxel.PAVANELLI, Ana Carolina; BARBOZA, Luciana Pizzatti; ABDELHAY, Eliana Saul Furquim Werneck; NAGAI, Maria Aparecida